Disparities by sex in P2Y 12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y 12 inhibitor new user retrospective cohort analysis of US Medicare claims data
- Ryan P. Hickson
- , Anna M. Kucharska-Newton
- , Jo E. Rodgers
- , Betsy L. Sleath
- , Gang Fang
Producción científica: Article › revisión exhaustiva
2
Citas
(Scopus)